API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2021/12/09/2349194/0/en/Aprea-Therapeutics-Announces-Removal-of-FDA-Clinical-Hold-on-Eprenetapopt-in-Lymphoid-Malignancies.html
https://www.globenewswire.com/news-release/2021/09/20/2300117/0/en/Aprea-Therapeutics-Presents-Data-From-Phase-1-2-Trial-of-Eprenetapopt-APR-246-in-Advanced-Solid-Tumors-at-ESMO-Congress-2021.html